Strategically Situated Across Key Regulatory Jurisdictions
Whether executing IND submissions in the United States, CTA filings under EU CTR 536/2014, or high-volume patient recruitment across Latin America and APAC, our hubs provide native-speaking teams and direct institutional access.
Montreal, Canada
4492 Sainte-Catherine St W, Suite 400
Westmount, QC H3Z 1R7, Canada
Direct Phone: +1 (514) 934-0805
Key Strengths: Phase I–IV Clinical Operations, Biostatistics, Epidemiology
Primary Agency: Health Canada (TPD / BGTD)
Boston & San Diego, USA
Cambridge Innovation Hub & Torrey Pines BioPark
Boston, MA & San Diego, CA, USA
Direct Phone: +1 (617) 849-9319
Key Strengths: US FDA Pre-IND Meetings, Biotech Clinical Programs
Primary Agency: US FDA (CDER / CBER / CDRH)
London, United Kingdom
25 Bank Street, Canary Wharf
London E14 5JP, United Kingdom
Direct Phone: +44 20 7946 0912
Key Strengths: MHRA Submissions, NHS Hospital Site Management
Primary Agency: MHRA & HRA
Warsaw, Poland
Al. Jerozolimskie 142B, Blue City
02-305 Warsaw, Poland
Direct Phone: +48 22 584 7200
Key Strengths: Fast Patient Enrollment, EU CTIS Submissions
Primary Agency: EMA / URPL
Mumbai & Faridabad, India
AstraClinical Center of Excellence, Corporate Zone
Navi Mumbai & Faridabad, India
Direct Phone: +91 7738804988
Key Strengths: End-to-End Safety/PV, Medical Writing, CDISC Data Mgmt
Primary Agency: CDSCO / US FDA Global
Bogotá, Colombia
Carrera 7 #116-50, Torre Cencosud
Bogotá, Colombia
Direct Phone: +57 1 744 3820
Key Strengths: LATAM Multi-Country Monitoring, High Retention Rates
Primary Agency: INVIMA / ANVISA